• Mashup Score: 3
    Heart Failure 2022 - 2 year(s) ago

    Unraveling epidemiology in heart failure Topic: Epidemiology, Prognosis, Outcome Session type: Moderated Posters Date: 23 May Start time: 07:40 End time: 08:25 Room: Moderated ePoster 1 Chairpersons Stephane Heymans (Cardiovascular Research Institute Maastricht (CARIM) – Maastricht, Netherlands (The)) PresentationsEstablished and novel adiposity measures and their association with incident…

    Tweet Tweets with this article
    • RT @ehjopen: Drop by the ePoster on Cardiac Resynchronization by @Ckhezst at #HeartFailure2022 https://t.co/9zPQtXH9r9 and read the article…

  • Mashup Score: 1
    Heart Failure 2022 - 2 year(s) ago

    Data Privacy: During the congress your online activity is tracked and collected by the ESC. We use this to award your CME credits; for reporting and statistical purposes; and to provide you with the best experience. Please note your details will be shared with the sponsor of any Industry Session, Tutorial or Exhibition you choose to view. More information is available in the Heart Failure 2022…

    Tweet Tweets with this article
    • RT @ehjopen: Drop by the ePoster on Cardiac Resynchronization by @Ckhezst at #HeartFailure2022 https://t.co/9zPQtXH9r9 and read the article…

  • Mashup Score: 0

    Early findings imply that speech changes in stable patients portend hospitalizations, offering a window of opportunity.

    Tweet Tweets with this article
    • Speech-Recognition Tool May Predict Worsening Congestion in #HF Early findings imply that speech changes in stable patients portend hospitalizations, offering a window of opportunity #HeartFailure2022 @TCTMD @ShelleyWood2 @ShelleyZieroth @mmamas1973 https://t.co/mvp1OUMTbc

  • Mashup Score: 0

    In what might prove the swan song for ERAs in HF, SERENADE tried to exclude patients with fluid retention—to no avail.

    Tweet Tweets with this article
    • SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH In what might prove the swan song for ERAs in HF, SERENADE tried to exclude patients with fluid retention—to no avail #HeartFailure2022 @TCTMD @ShelleyWood2 @mmamas1973 @TCTMD_Yael https://t.co/XTZftHPwqC